The European molecular oncology diagnostics sector is experiencing significant growth, driven by several key factors. Increasing incidence rates of cancer across Europe, coupled with advancements in molecular diagnostic technologies, are stimulating demand for precise and accurate diagnostic tools. Furthermore, the implementation of personalized me